TTrialPathMatch Me to Trials
← Back to trials
RecruitingKnee Osteoarthritis (Knee OA)Chronic PainChronic Knee Pain

Personalized Analgesia Through Central Nervous System Engagement to Unlock Performance

Eligible age

45–80 yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The goal of this clinical trial is to examine the effects of duloxetine on walking ability and physical activity in patients with knee osteoarthritis. Researchers will compare duloxetine to a placebo (a look-alike substance that contains no drug) to see if duloxetine works to improve walking ability in patients with knee osteoarthritis. At study visits, participants will complete surveys, perform physical function tasks, undergo non-invasive brain imaging, and undergo sensory testing.

Sponsor: Benedict Alter

You may qualify if…

  • ✓ Knee pain for greater than 6 months.
  • ✓ Moderate-to-severe knee pain (\>3/10) due to osteoarthritis, as defined by American College of Rheumatology and EULAR diagnostic criteria (Zhang 2010, Altman 1986) on \>50% of days in the past month.
  • ✓ KL grade 2-4 (Kellgren and Lawrence 1957) indicating significant degenerative changes on knee X-ray. This will be determined on evaluation of weight-bearing clinical X-rays on review of medical records. In the infrequent situation that the patient does not have an X-ray on review of their medical records, then the patient will obtain weight-bearing knee X-rays as part of the Screening Visit.
  • ✓ Age: 45-80 years old
  • ✓ Gender: Males and females will be recruited.
  • ✓ Language: only English-speaking subjects will be included.

You may not qualify if…

  • ✕ Inflammatory arthritis (e.g. rheumatoid arthritis).
  • ✕ More intense pain due to another chronic pain syndrome (e.g. fibromyalgia, hip osteoarthritis)
  • ✕ Significant pain or weakness in the lower extremities due to a neurological condition (e.g. lumbar radiculopathy, paresis due to stroke)
  • ✕ New, ongoing acute pain
  • ✕ Recent use of duloxetine defined as any use within the last 3 months
  • ✕ Current use of antidepressants or tramadol
  • ✕ Current routine use of more than 30 mg oral morphine equivalents per day (use of \<=30 mg OME does not exclude the participant).
  • ✕ New treatment that may help knee osteoarthritis (including medication, exercise, behavioral, or complementary and integrative treatments) started in the last month. Stable use of treatments for greater than 1 month does not exclude the participant.

Where it's recruiting

Pennsylvania

Pittsburgh

Source: ClinicalTrials.gov · NCT07759336 · last updated 2026-10-21

Personalized Analgesia Through Central Nervous System Engagement to Un · TrialPath